Our Mission
The HPTN develops and evaluates cutting-edge biomedical, behavioral, and structural interventions to reduce the transmission of HIV.
Innovative, transformative, and impactful
23
Active Studies
55
Study Sites
13
Countries
541
Publications
Our Research Agenda
The HPTN research agenda focuses on four strategies:
- Long-acting antiretroviral (ARV) agents for pre-exposure prophylaxis (PrEP)
- Multipurpose prevention technologies (MPTs)
- Broadly neutralizing antibodies (bnAbs)
- Integrated strategies for HIV prevention
Happening at HPTN
The 2025 HPTN Annual Meeting
Thank you to those who attended to all-virtual 2025 HPTN Annual Meeting. We are not permitted to share or distribute any presentations or materials from the meeting. Registered attendees may revisit completed presentations by viewing the recording from within the event platform.
Read more
Fostering the next era of researchers
HPTN Scholars Program
The HPTN Scholars Program seeks to provide scholar recipients with the knowledge, skills, and connections to further their careers as independent investigators in the HIV prevention research field.
Learn More